NCT04532632

Brief Summary

Evaluating the smell and taste perceptions of patients hospitalized in the intensive care unit with suspicion of Coronavirus disease-19 diagnosis with a survey study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 31, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 9, 2020

Completed
Last Updated

November 10, 2020

Status Verified

November 1, 2020

Enrollment Period

1 month

First QC Date

August 28, 2020

Last Update Submit

November 7, 2020

Conditions

Keywords

Coronavirus disease-19anosmiahyposmiadysgeusia

Outcome Measures

Primary Outcomes (1)

  • taste and smell impairment

    incidence of taste and smell impairment in critically ill subjects

    up to 3 months

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients between the ages of 18-80, who were treated in the intensive care unit with the diagnosis of Coronavirus disease-19 and were discharged

You may qualify if:

  • Adults between the ages of 18-80
  • Agree to participate in the study
  • Patients treated in the intensive care unit with the diagnosis of Coronavirus disease-19

You may not qualify if:

  • Pre-existing smell and taste impairment
  • The patients have no enough cooperation to answer the questionnaire
  • Having additional diseases such as dementia and Alzheimer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sisli Etfal Research and Training Hospital

Istanbul, 34371, Turkey (Türkiye)

Location

Related Publications (2)

  • Hopkins C, Surda P, Whitehead E, Kumar BN. Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J Otolaryngol Head Neck Surg. 2020 May 4;49(1):26. doi: 10.1186/s40463-020-00423-8.

    PMID: 32366299BACKGROUND
  • Sayin I, Yasar KK, Yazici ZM. Taste and Smell Impairment in COVID-19: An AAO-HNS Anosmia Reporting Tool-Based Comparative Study. Otolaryngol Head Neck Surg. 2020 Sep;163(3):473-479. doi: 10.1177/0194599820931820. Epub 2020 Jun 9.

    PMID: 32513096BACKGROUND

MeSH Terms

Conditions

Olfaction DisordersTaste DisordersCoronavirus InfectionsCOVID-19AnosmiaDysgeusia

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesInfectionsPneumonia, ViralPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
10 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
specialist medical doctor

Study Record Dates

First Submitted

August 28, 2020

First Posted

August 31, 2020

Study Start

September 1, 2020

Primary Completion

October 1, 2020

Study Completion

October 9, 2020

Last Updated

November 10, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations